Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2017 Jun;13(6):613-623.
doi: 10.1016/j.jalz.2016.11.003. Epub 2016 Dec 23.

Risk of incident clinical diagnosis of Alzheimer's disease-type dementia attributable to pathology-confirmed vascular disease

Affiliations
Multicenter Study

Risk of incident clinical diagnosis of Alzheimer's disease-type dementia attributable to pathology-confirmed vascular disease

Hiroko H Dodge et al. Alzheimers Dement. 2017 Jun.

Abstract

Introduction: The presence of cerebrovascular pathology may increase the risk of clinical diagnosis of Alzheimer's disease (AD).

Methods: We examined excess risk of incident clinical diagnosis of AD (probable and possible AD) posed by the presence of lacunes and large infarcts beyond AD pathology using data from the Statistical Modeling of Aging and Risk of Transition study, a consortium of longitudinal cohort studies with more than 2000 autopsies. We created six mutually exclusive pathology patterns combining three levels of AD pathology (low, moderate, or high AD pathology) and two levels of vascular pathology (without lacunes and large infarcts or with lacunes and/or large infarcts).

Results: The coexistence of lacunes and large infarcts results in higher likelihood of clinical diagnosis of AD only when AD pathology burden is low.

Discussion: Our results reinforce the diagnostic importance of AD pathology in clinical AD. Further harmonization of assessment approaches for vascular pathologies is required.

Keywords: Alzheimer's disease pathology; Community sample; Population Attributable Risk%; SMART consortium; Vascular pathology.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Sample Size Flow Chart

Similar articles

Cited by

References

    1. Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol. 2011;10:819–828. - PMC - PubMed
    1. Ritchie K, Ritchie CW, Jaffe K, Skoog I, Scarmeas N. Is late-onset Alzheimer's disease really a disease of midlife? Alzheimer's & dementia : translational research & clinical interventions. 2015;1:122–130. - PMC - PubMed
    1. Dodge HH, Chang CC, Kamboh MI, Ganguli M. Risk of Alzheimer's disease incidence atrributable to vascular disease in the population. Alzheimer's & Dementia. 2011;7:356–360. - PMC - PubMed
    1. Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C. Potential for primary prevention of Alzheimer's disease: an analysis of population-based data. Lancet Neurol. 2014;13:788–794. - PubMed
    1. Viswanathan A, Rocca WA, Tzourio C. Vascular risk factors and dementia: how to move forward? Neurology. 2009;72:368–374. - PMC - PubMed

Publication types

Substances